Gut-Brain Axis
The Gut–Brain Axis and the Future of Microbiome-Directed Mental Health Strategies
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-22May 25, 2026
Psychedelics CMC
The CMC Challenge for Psychedelic Drugs
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-21May 22, 2026
Psych R&D
Rebuilding the Psychiatric Drug Discovery Pipeline
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-14May 13, 2026
Psych Biomarkers
Beyond Symptoms: The Search for Objective Biomarkers in Psychiatric Disorders
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-13May 12, 2026
Psychedelics
Psychedelic Therapeutics at an Inflection Point: Translating Clinical Signals into Scalable Medicines
David Alvaro, Ph.D.
Pharma's Almanac
PAO-05-26-PA-07May 6, 2026